Condition: Moderately to Severely Active Ulcerative Colitis · Sponsor: Hoffmann-La Roche
This Phase III, multicenter, double-blind, placebo-controlled study will evaluate the efficacy and safety of induction therapy with Afimkibart (RO7790121) compared with placebo in participants with moderately to severely active ulcerative colitis (UC).
This description comes directly from the study's public registry record.
Reference Study ID Number: GA45330 https://forpatients.roche.com/ No attachments to email below. · 888-662-6728 (U.S. and Canada) · global-roche-genentech-trials@gene.com
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Always discuss trial participation with your own doctor first.
| Digestive Health Specialists of the Southeast (Gastroenterology Associates of Dothan) - Dothan | Dothan, Alabama, United States | Recruiting |
| Mayo Clinic Hospital | Scottsdale, Arizona, United States | Recruiting |
| Arizona Digestive Health, P.C (ADH) | Sun City, Arizona, United States | Recruiting |
| Om Research LLC | Apple Valley, California, United States | Recruiting |
| Valley View Internal Medicine | Garden Grove, California, United States | Recruiting |
| Gastro Care Associates | Lancaster, California, United States | Recruiting |
| University of Southern California | Los Angeles, California, United States | Recruiting |
| Hoag Memorial Hospital Presbyterian;Hoag Center for Research and Education | Newport Beach, California, United States | Recruiting |
| Stanford Medicine Outpatient Center | Redwood City, California, United States | Recruiting |
| Peak Gastroenterology Associates | Colorado Springs, Colorado, United States | Recruiting |
| Hi Tech and Global Research, LLC | Coral Gables, Florida, United States | Recruiting |
| The Sister Life Research | Hialeah, Florida, United States | Recruiting |
+ 188 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06588855